BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...Donaldson as CFO. He succeeds Erik Ostrowski, who left the antibiotics company in December 2018. Donaldson...
BioCentury | Oct 12, 2015
Emerging Company Profile

Balancing VEGF

...Disease focus: Ophthalmology, cancer Clinical status: Preclinical Founded: 2013 by David Bates, Steven Harper, Lucy Donaldson...
BioCentury | Oct 31, 2013
Cover Story

Building meditope-enabled mAbs

...Pasadena, Calif. Merck KGaA (Xetra:MRK), Darmstadt, Germany Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland References 1. Donaldson...
...Aug. 19, 2013 Figures Figure 1: Meditope-enabled mAbs Figure 1. Meditope-enabled mAbs. As reported by Donaldson...
BioCentury | Oct 31, 2013
Distillery Techniques

Technology: Drug platforms

...applications filed by City of Hope; exclusively licensed to Meditope; available for partnering through Meditope Donaldson...
BioCentury | Aug 28, 2006
Finance

Ebb & Flow

...companies at PaineWebber, and before was a biotech analyst at Drexel Burnham Lambert and at Donaldson...
BioCentury | Apr 24, 2006
Regulation

Darning SOX

...being spent on research to benefit humanity," he said. A year's review Then-SEC Chairman William Donaldson...
BioCentury | Jun 14, 2004
Company News

Angiotech management update

...as VP of business development, formerly a senior banker with Credit Suisse First Boston and Donaldson...
BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...head of U.S. biotech equity research at Lehman Brothers. Parker was a sellside analyst with Donaldson...
BioCentury | Jun 12, 2002
Financial News

Parker joins Lehman

...Parker had managed Immunex's oncology franchise following a stretch of sellside analyst work at both Donaldson...
BioCentury | Apr 30, 2001
Finance

Ebb & Flow

...Biotech affiliate Pulsar International, will remain on KOSN's board. Wall Street tracks eMedsecurities hired former Donaldson...
Items per page:
1 - 10 of 36
BioCentury | Jun 20, 2020
Management Tracks

Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more

...Donaldson as CFO. He succeeds Erik Ostrowski, who left the antibiotics company in December 2018. Donaldson...
BioCentury | Oct 12, 2015
Emerging Company Profile

Balancing VEGF

...Disease focus: Ophthalmology, cancer Clinical status: Preclinical Founded: 2013 by David Bates, Steven Harper, Lucy Donaldson...
BioCentury | Oct 31, 2013
Cover Story

Building meditope-enabled mAbs

...Pasadena, Calif. Merck KGaA (Xetra:MRK), Darmstadt, Germany Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland References 1. Donaldson...
...Aug. 19, 2013 Figures Figure 1: Meditope-enabled mAbs Figure 1. Meditope-enabled mAbs. As reported by Donaldson...
BioCentury | Oct 31, 2013
Distillery Techniques

Technology: Drug platforms

...applications filed by City of Hope; exclusively licensed to Meditope; available for partnering through Meditope Donaldson...
BioCentury | Aug 28, 2006
Finance

Ebb & Flow

...companies at PaineWebber, and before was a biotech analyst at Drexel Burnham Lambert and at Donaldson...
BioCentury | Apr 24, 2006
Regulation

Darning SOX

...being spent on research to benefit humanity," he said. A year's review Then-SEC Chairman William Donaldson...
BioCentury | Jun 14, 2004
Company News

Angiotech management update

...as VP of business development, formerly a senior banker with Credit Suisse First Boston and Donaldson...
BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...head of U.S. biotech equity research at Lehman Brothers. Parker was a sellside analyst with Donaldson...
BioCentury | Jun 12, 2002
Financial News

Parker joins Lehman

...Parker had managed Immunex's oncology franchise following a stretch of sellside analyst work at both Donaldson...
BioCentury | Apr 30, 2001
Finance

Ebb & Flow

...Biotech affiliate Pulsar International, will remain on KOSN's board. Wall Street tracks eMedsecurities hired former Donaldson...
Items per page:
1 - 10 of 36